MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ijd.14397

Медицинская библиотека · International journal of dermatology · 2019

Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in Greece.

Befon Angeliki, Tzanetakou Vassiliki, Panagiotopoulos Antonios, Chasapi Vasiliki, Antoniou Christina, Stratigos Alexander J

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Imiquimod 3.75% is a field-directed treatment for actinic keratosis that can detect and treat clinical and subclinical lesions across an entire sun-exposed field. The detection of subclinical lesions is evidenced by an increase in lesions to the maximum lesion count during treatment (Lmax ). We report clinical outcomes for the first 15 patients treated with imiquimod 3.75% in daily clinical practice in Greece.

METHODS

Fifteen patients with actinic keratosis lesions were treated with imiquimod 3.75% in an outpatient setting in two 2-week treatment cycles separated by a 2-week treatment-free interval. Actinic keratosis lesions were counted before treatment, at the end of the first treatment cycle (Week 2; Lmax ), and 2 weeks after the second treatment cycle (Week 8). Local skin reactions (LSR) were also evaluated at Weeks 2 and 8.

RESULTS

The median baseline actinic keratosis lesion count was 25, which increased to a median Lmax of 29 at Week 2 and decreased to a median of 5 at Week 8. The median percentage and absolute reduction in actinic keratosis lesions from Lmax to Week 8 were 87% and 23%, respectively. Most of the LSR were mild-to-moderate in intensity at Week 2 and had resolved by Week 8.

CONCLUSION

Imiquimod 3.75% effectively detected and cleared both the clinical and subclinical actinic keratosis lesions across the entire sun-exposed field in this cohort of Greek patients. Treatment was well tolerated.

Для цитирования: Befon Angeliki, Tzanetakou Vassiliki, Panagiotopoulos Antonios, Chasapi Vasiliki, Antoniou Christina, Stratigos Alexander J. Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in Greece.. International journal of dermatology. 2019. DOI: 10.1111/ijd.14397.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.